Who is sponsoring NCT05347953?

NCT05347953 is sponsored by Catharina Ziekenhuis Eindhoven.

What drugs are being tested in NCT05347953?

Interventions in NCT05347953: Single night downgraded home polygraphy.

What condition does NCT05347953 study?

NCT05347953 studies Cardiac Complexes, Premature, Atrial Fibrillation.

Is NCT05347953 still recruiting?

NCT05347953 is currently status unknown. Last updated 27 April 2022.

Last reviewed 2022-04-27 · How we verify

NCT05347953

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gravitational Arrhythmogenesis Can the Often-heard Symptom of Body Position Dependent Palpitations be Proven

Status unknown Last updated 27 April 2022

What this trial tests

trial testing Single night downgraded home polygraphy in Cardiac Complexes, Premature in 100 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
1 June 2023

1 September 2024

Quick facts

Lead sponsor	Catharina Ziekenhuis Eindhoven
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 June 2022
Primary completion	1 June 2023
Estimated completion	1 September 2024
Sites	1 location across Netherlands

Drugs / interventions tested

Single night downgraded home polygraphy

Conditions studied

Cardiac Complexes, Premature — all drugs for Cardiac Complexes, Premature →
Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

Catharina Ziekenhuis Eindhoven — full company profile →

Who can join

18 and older, any sex, with Cardiac Complexes, Premature or Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the relationship between body position and the occurrence of either atrial or ventricular premature beats and more complex arrhythmia

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Catharina Ziekenhuis Eindhoven trials

Trials by the same sponsor.

NCT07314138 — Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-pump Coronar · NA · not yet recruiting
NCT06768060 — Mindfulness-based Intervention Prior to External Cephalic Version · NA · recruiting
NCT06574867 — Evaluation of the viQtor Monitoring Solution on Surgical Wards · recruiting
NCT06374836 — The Contractile Response of the Thoracic Aorta to Vasoactive Substances · completed
NCT06401291 — Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05347953 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Catharina Ziekenhuis Eindhoven
Last refreshed: 27 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05347953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing